FR1597530A - - Google Patents

Info

Publication number: FR1597530A
Authority: FR; France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1967-09-15

Filing date

1968-09-13

Publication date

1970-06-29

1968-09-13 Application filed filed Critical

1970-06-29 Application granted granted Critical

1970-06-29 Publication of FR1597530A publication Critical patent/FR1597530A/fr

Status Expired legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

FR1597530D 1967-09-15 1968-09-13 Expired FR1597530A (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
DEF0053504		1967-09-15
LU57488		1968-12-06
US21852472A	1972-01-17	1972-01-17

Publications (1)

Publication Number	Publication Date
FR1597530A true FR1597530A (fr)	1970-06-29

Family

ID=27210542

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
FR1597530D Expired FR1597530A (fr)	1967-09-15	1968-09-13
FR177895A Expired FR8112M (fr)	1967-09-15	1968-12-12

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
FR177895A Expired FR8112M (fr)	1967-09-15	1968-12-12

Country Status (5)

Country	Link
US (16)	US3660577A (fr)
BE (1)	BE720801A (fr)
FR (2)	FR1597530A (fr)
GB (1)	GB1170188A (fr)
LU (1)	LU57488A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH513893A (de) *	1968-07-20	1971-10-15	Bayer Ag	Verfahren zur Herstellung von N-Diaryl-pyridylmethyl-imidazolen und deren Salzen
IL33324A (en) *	1968-11-29	1972-09-28	Bayer Ag	N-substituted imidazoles and their salts,their production,and pharmaceutical preparations containing them
DE2009020C3 (de) *	1970-02-26	1979-09-13	Bayer Ag, 5090 Leverkusen	Verfahren zur Herstellung von N-(l,l,l-trisubstituierten)-Methylazolen
US3980780A (en) *	1970-03-23	1976-09-14	Bayer Aktiengesellschaft	N-Methyl-imidazole derivatives for treating mycotic infections
US3764609A (en) *	1970-06-22	1973-10-09	Koninklijke Pharma Fab Nv	1 (dibenzo {8 4,d{9 {0 cyclohepten-5-yl), 1-(dibenzo {8 a,d{9 {0 cycloheptan-5-yl) and 1-(dibenzo {8 a,d{9 {0 cyclooctanyl)imidazoles
DE2037610A1 (de) *	1970-07-29	1972-02-03	Bayer Ag	Neue alpha-substituierte Benzyl-azole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2213863C3 (de) *	1972-03-22	1982-05-13	Bayer Ag, 5090 Leverkusen	Disubstituierte Triphenylmethylimidazole, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
US4117142A (en) *	1972-03-22	1978-09-26	Bayer Aktiengesellschaft	Disubstituted triphenylmethylmidazoles for treating mycotic infections
DE2314985A1 (de) *	1973-03-26	1974-10-17	Hoechst Ag	1-(imidazol-1-yl)-isochinoline und verfahren zu ihrer herstellung
JPS6048486B2 (ja) *	1976-01-01	1985-10-28	木場常義	抗リウマチ剤
FR2387658A1 (fr) *	1977-03-25	1978-11-17	Ciba Geigy Ag	Procede pour combattre les microorganismes
US4267169A (en) *	1978-07-22	1981-05-12	Toko Yakuhin Kogyo Kabushiki Kaisha	Novel preparation of clotrimazole
US4216333A (en) *	1978-10-30	1980-08-05	Sumitomo Chemical Company, Limited	Process for preparing N-tritylimidazole compounds
US4439441A (en) *	1979-01-11	1984-03-27	Syntex (U.S.A.) Inc.	Contraceptive compositions and methods employing 1-substituted imidazole derivatives
JPS5692887A (en) *	1979-12-05	1981-07-27	Sumitomo Chem Co Ltd	N-substituted imidazole derivative
JPS58150566A (ja) *	1982-03-03	1983-09-07	Yoshitomi Pharmaceut Ind Ltd	新規イミダゾ−ル誘導体
US4755526A (en) *	1984-06-18	1988-07-05	Eli Lilly And Company	Method of inhibiting aromatase
US4775678A (en) *	1984-10-01	1988-10-04	Schering Corporation	Clotrimazole cream
US4978672A (en) *	1986-03-07	1990-12-18	Ciba-Geigy Corporation	Alpha-heterocyclc substituted tolunitriles
US4937250A (en) *	1988-03-07	1990-06-26	Ciba-Geigy Corporation	Alpha-heterocycle substituted tolunitriles
US4749713A (en) *	1986-03-07	1988-06-07	Ciba-Geigy Corporation	Alpha-heterocycle substituted tolunitriles
EP0352352B1 (fr) *	1988-07-28	1991-10-16	J. URIACH & CIA. S.A.	[(Fluoro-2-phényl)(fluoro-4-phényl)phénylméthyl]-1-1H-imidazole
US5177099A (en) *	1989-04-10	1993-01-05	Sociedad Espanola De Especialidades Farmaco-Terapeuticas S.A.	Dichloro-substituted imidazole derivatives as antifungal agents
CA2035758C (fr) *	1990-03-06	2002-04-02	Yataka Murata	Preparations antimycotiques a base d'imidazole pour usage externe
WO1993025238A1 (fr) *	1992-06-08	1993-12-23	Schering-Plough Healthcare Products, Inc.	Compositions de poudres antifongiques stables contenant de l'imidazole
US6177427B1 (en) *	1994-06-28	2001-01-23	Alcon Laboratories, Inc.	Treatment of glaucoma and ocular hypertension
EP1052990A2 (fr) *	1997-11-14	2000-11-22	Neurosearch A/S	Composes chimiques ayant une activite de blocage des canaux ioniques et servant au traitement de troubles immunitaires
US6103733A (en) *	1998-09-09	2000-08-15	Bachmann; Kenneth A.	Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes
US6080744A (en) *	1999-02-10	2000-06-27	Ayon-Covarrubias; Blas	Topical antifungal treatment
US6450515B1 (en) *	2000-10-10	2002-09-17	James F. Guth	Clip-on wheels for pallets or other structures with runners
US20060211632A1 (en) *	2005-03-17	2006-09-21	Bachmann Kenneth A	PXR agonists for cardiovascular disease
EP1958613A1 (fr) *	2007-02-15	2008-08-20	Polichem S.A.	Formulations liquides filmogènes pour la libération des médicaments sur la peau
CL2008003553A1 (es) *	2007-12-05	2009-11-27	Grindeks Jsc	Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
BRPI0904249B1 (pt)	2009-08-28	2018-03-06	Biolab Sanus Farmacêutica Ltda.	Compostos éteres aralquil benzílicos, processo de preparação dos mesmos, uso dos referidos compostos, composição farmacêutica
ES2683864T3 (es)	2009-10-01	2018-09-28	Adare Pharmaceuticals, Inc.	Composiciones de corticosteroides administradas oralmente
WO2015034678A2 (fr)	2013-09-06	2015-03-12	Aptalis Pharmatech, Inc.	Corticostéroïde contenant des compositions de comprimés se désintégrant par voie orale pour œsophagite à éonisophiles
JP6723698B2 (ja) *	2015-07-23	2020-07-15	東京応化工業株式会社	微粒子含有組成物
US20170112824A1 (en) *	2015-10-23	2017-04-27	Wright State University	Combination therapies for the treatment of fungal infections
TWI728172B (zh)	2016-08-18	2021-05-21	美商愛戴爾製藥股份有限公司	治療嗜伊紅性食道炎之方法
US11185548B2 (en)	2016-12-23	2021-11-30	Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh)	Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3321366A (en) *	1965-11-15	1967-05-23	Dow Chemical Co	Fungicidal methods and compositions

1968
- 1968-09-03 GB GB41773/68A patent/GB1170188A/en not_active Expired
- 1968-09-09 US US758594A patent/US3660577A/en not_active Expired - Lifetime
- 1968-09-13 BE BE720801D patent/BE720801A/xx not_active IP Right Cessation
- 1968-09-13 FR FR1597530D patent/FR1597530A/fr not_active Expired
- 1968-12-06 LU LU57488D patent/LU57488A1/xx unknown
- 1968-12-12 FR FR177895A patent/FR8112M/fr not_active Expired
1970
- 1970-02-24 US US13797A patent/US3705172A/en not_active Expired - Lifetime
- 1970-05-11 US US36426A patent/US3655900A/en not_active Expired - Lifetime
- 1970-05-11 US US36425A patent/US3655899A/en not_active Expired - Lifetime
- 1970-05-11 US US36394A patent/US3657442A/en not_active Expired - Lifetime
- 1970-05-11 US US36424A patent/US3658956A/en not_active Expired - Lifetime
- 1970-05-11 US US36396A patent/US3660576A/en not_active Expired - Lifetime
- 1970-05-11 US US36395A patent/US3657445A/en not_active Expired - Lifetime
1971
- 1971-03-19 US US00126277A patent/US3720770A/en not_active Expired - Lifetime
- 1971-07-09 US US00161274A patent/US3839573A/en not_active Expired - Lifetime
1972
- 1972-01-17 US US00218519A patent/US3767668A/en not_active Expired - Lifetime
- 1972-01-17 US US00218521A patent/US3711498A/en not_active Expired - Lifetime
- 1972-01-17 US US00218524A patent/US3717657A/en not_active Expired - Lifetime
- 1972-01-17 US US00218526A patent/US3711501A/en not_active Expired - Lifetime
- 1972-01-17 US US00218525A patent/US3711500A/en not_active Expired - Lifetime
- 1972-01-17 US US00218523A patent/US3711499A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US3655899A (en)	1972-04-11
US3658956A (en)	1972-04-25
GB1170188A (en)	1969-11-12
US3711498A (en)	1973-01-16
US3711500A (en)	1973-01-16
DE1617481A1 (de)	1971-04-08
BE720801A (fr)	1969-03-13
LU57488A1 (fr)	1969-03-13
US3767668A (en)	1973-10-23
US3705172A (en)	1972-12-05
US3660576A (en)	1972-05-02
US3711499A (en)	1973-01-16
US3655900A (en)	1972-04-11
US3657445A (en)	1972-04-18
US3657442A (en)	1972-04-18
US3711501A (en)	1973-01-16
US3720770A (en)	1973-03-13
US3660577A (en)	1972-05-02
DE1617481B2 (de)	1975-07-24
US3839573A (en)	1974-10-01
US3717657A (en)	1973-02-20
FR8112M (fr)	1970-07-27

Publication	Publication Date	Title
AU425114B2 (fr)	1972-06-14
FR1597530A (fr)	1970-06-29
AU416737B2 (fr)	1971-09-03
AU342066A (fr)	1968-09-19
AU2277767A (fr)	1968-12-12
AU1273466A (fr)	1969-04-24
AU610966A (fr)	1968-11-28
AU2977667A (fr)	1969-05-22
AU2116667A (fr)	1969-04-03
AU2256867A (fr)	1968-12-05
AU3189468A (fr)	1969-07-10
AU2454867A (fr)	1969-01-16
AU3151267A (fr)	1968-01-08
AU2528767A (fr)	1970-01-08
BE711559A (fr)	1968-07-15
BE483855A (fr)
AU25066A (fr)	1968-07-11
AU2406369A (fr)	1969-01-09
AU1868267A (fr)	1968-09-12
AU34866A (fr)	1968-07-04
AU408412B2 (fr)	1970-11-23
AU1763766A (fr)	1968-08-15
BE711379A (fr)	1968-08-28
AU1677166A (fr)	1968-07-25
AU1614766A (fr)	1968-07-11

Legal Events

Date	Code	Title	Description
1985-07-26	ST	Notification of lapse